In this regard increased expression of WT1 is associated with the development and progression of different human cancers [20], [29], including carcinomas of the lung [30], breast [31], colon [32], pancreas [33], desmoid tumors [34], hematopoietic system tumors [35]–[36], rhabdomyosarcoma [37]–[39], myofibroblastoma [40], melanoma [41] and brain tumors [42]–[44]. Here, WT1 is linked to melanoma.